Incyte to Present at Upcoming Investor Conference
Provided By Business Wire
Last update: May 1, 2025
Incyte (Nasdaq:INCY) announced today that it will present at the 2025 BofA Securities Health Care Conference on Tuesday, May 13, 2025 at 1:40 pm (PDT).
The presentation will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.
About Incyte
A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.
For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn, X, Instagram, Facebook, YouTube.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250501277871/en/
62.53
+0.5 (+0.81%)
Find more stocks in the Stock Screener
INCY Latest News and Analysis
4 days ago - ChartmillDiscover the top S&P500 movers in Tuesday's after-hours session.After the conclusion of the US market's regular session on Tuesday, let's examine the after-hours session and unveil the notable S&P500 performers among the top gainers and losers.
4 days ago - ChartmillTuesday's pre-market session: top gainers and losers in the S&P500 indexThe US market session of Tuesday has yet to be opened, let's have a look at the top S&P500 gainers and losers in the pre-market session today.
19 days ago - ChartmillINCYTE CORP (NASDAQ:INCY) is probably undervalued for the fundamentals it is displaying.Take a closer look at INCYTE CORP , a remarkable value stock. NASDAQ:INCY excels in fundamentals and maintains a very reasonable valuation.
